Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIRT2 | Q8IXJ6 | 15/20 | 0.49 |
| ▸ | CA1 | P00915 | 1/20 | 0.46 |
| ▸ | CA2 | P00918 | 1/20 | 0.46 |
| ▸ | SIRT1 | Q96EB6 | 12/20 | 0.46 |
| ▸ | SIRT3 | Q9NTG7 | 8/20 | 0.46 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.42 |
| ▸ | PTGER4 | P35408 | 2/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28820387 | 0.93 | SIRT2 (0.51) | SIRT2SIRT1SIRT3FOLH1ALDH1A1 | |
| SCHEMBL21715244 | 0.89 | CA1 (0.54) | CA1CA2FOLH1PTGER4 | |
| SCHEMBL16762298 | 0.89 | CA1 (0.54) | CA1CA2FOLH1PTGER4 | |
| SCHEMBL31277511 | 0.82 | SIRT2 (0.51) | SIRT2SIRT1SIRT3FOLH1ALDH1A1 | |
| SCHEMBL21543891 | 0.82 | SIRT2 (0.51) | SIRT2SIRT1SIRT3FOLH1ALDH1A1 | |
| SCHEMBL16762202 | 0.82 | FOLH1 (0.52) | CA1CA2FOLH1 | |
| SCHEMBL28948762 | 0.79 | SIRT2 (0.47) | SIRT2SIRT1SIRT3FOLH1ALDH1A1 | |
| SCHEMBL21715232 | 0.79 | CTSL (0.55) | SIRT2SIRT1SIRT3ALDH1A1GAA | |
| SCHEMBL21543552 | 0.79 | MAPT (0.57) | FOLH1 | |
| SCHEMBL21715254 | 0.79 | CTSK (0.53) | SIRT2SIRT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107820429-B | Novel compositions and methods for immunotherapy comprising small molecule integrin receptor-ligand agonist adjuvants | 7山药物有限责任公司 | 2022-08-16 | — | — | CN | disclosed |